I like Slovakian approach. Price of drugs can't be higher than average of 5 cheapest EU countries where the drug is being sold. However we face re-exporting and

I like Slovakian approach. Price of drugs can't be higher than average of 5 cheapest EU countries where the drug is being sold. However we face re-exporting and sometimes unavailability. Also we have a new law where distributor will lose licence if the drug is un-available (recent update). https://www.ncbi.nlm.nih.gov/pubmed/29073987 https://www.ncbi.nlm.nih.gov/pubmed/29073987